Noreen Manning

Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX.

Dianon Systems, Inc. provides anatomic pathology, genetic, and clinical chemistry testing services. The firm offers services in uropathology, dermatopathology, gastrointestinal pathology, hematopathology, and breast pathology. The company was founded in 1983 and is headquartered in Stratford, CT.

Micronics, Inc. develops molecular and immuno-hematology diagnostic products. Its products include PanNAT molecular diagnostic system, immunohematology diagnostic products and research & development products. The company was founded in 1996 and is headquartered in Redmond, WA.

Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom.

BioTrove, Inc. develops, manufactures and markets systems, consisting of laboratory instruments and related consumables, for genomic analysis, high-throughput screening and molecular diagnostics. The company was founded by Tanya S. Kanigan and Colin J. H. Brenan in 2000 and is headquartered in Woburn, MA.

Cardiocore Lab LLC provides cardiac testing services The company was founded in 1992 and is headquartered in Bethesda, MD.

Apervita, Inc. operates a health analytics marketplace. It enables providers, payers and stakeholders to connect, build and share critical applications that improve consumer and clinician experience, and healthcare outcomes. The company was founded by Paul J. Magelli Jr., Brad Ryan and Geoffrey Phillips in 2012 and is headquartered in Chicago, IL.

Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands.

Cortek, Inc. develops and markets spinal products. Its products are used in the treatment of chronic back pain. It currently markets allografts and proprietary instrument systems for anterior lumbar interbody fusion (ALIF), posterior lumbar interbody fusion (PLIF) and cervical fusion procedures. The company is headquartered in Dedham, MA.

TomoTherapy, Inc. manufactures and provides radiation treatment systems for advanced radiation therapy. It provides radiation treatment services for cancer patients with its TomoTherapy Hi·Art System, which changes the intensity of the radiation beam so that it adapts to the shape of the tumor. The firm's system focuses on killing cancer cells while sparing healthy tissue. The company was founded by Thomas Rockwell Mackie and Paul J. Reckwerdt in 1997 and is headquartered in Madison, WI.

Robert W. Baird & Co., Inc./Venture Partners/ (Baird Venture) is a venture capital division of Robert W. Baird & Co., Inc. founded in 2000 by Thomas Desmond. The firm is headquartered in Chicago, Illinois.

Robert W. Baird & Co., Inc. operates as a wealth management, capital markets, private equity and asset management firm. It offers equity research, corporate restructuring, mergers and acquisitions, public financing and fixed income services. The firm serves individual, corporate, institutional and municipal clients. The company was founded by Robert Wilson Baird in 1919 and is headquartered in Milwaukee, WI.

Founded in 1987, BioForward is a member-driven state association and venture capital investor located in Madison, Wisconsin. The firm serves as the voice of Wisconsin's bioscience industry. They advocate on their members behalf to create investment and partnership opportunities, attract and retain the best people and support public policy that fosters their continued growth. BioForward also provides member-support services including networking opportunities through a variety of conferences and events, online resources and group purchasing programs. Their members include bioscience companies, universities, non-profit organizations, service providers, as well as state, regional and local government representatives. BioForward was previously known as the Wisconsin Biotechnology & Medical Device Association.

bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC.

NeoChord, Inc. develops medical devices. It offers NeoChord, a disposable device that replaces damaged chordae through a small incision while the heart is beating. The company was founded in 2007 and is headquartered in St. Louis Park, MN.

Insightra Medical, Inc. develops medical devices. It offers QuickWIT, a cardiology wire insertion tool, sensiPull, an ergonomic aortic punch, and the Modulare, a catheter stabilization device. The firm also offers innovative solutions for the common disease of inguinal hernias and ventral hernia. The company was founded by Bradley J. Sharp in March 2001 and is headquartered in Irvine, CA.

GreenLight Biosciences, Inc. engages in a biotechnology company.. It delivers attractive solution for production of chemicals and fuels from renewable resources, eliminating the need for petroleum feedstocks. The company was founded by Andrey J. Zarur, Marta Ortega-Valle, and James R. Swartz and is headquartered in Medford, MA.

Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA.

Zurex Pharma, Inc. provides safe and effective anti-microbial products. Its products include ZuraPrep, a pre-surgical skin preparation for the prevention of SSI; ZurAsept, an antimicrobial and antithrombotic catheter solution to reduce CRBSI; and ZuraGard that prevents extra-luminal or exit site wound CRBSI. The company was founded in April 2008 and is headquartered in Middleton, WI.

Innovation Development Institute, Inc. operates as a community of healthcare innovators who aspire to heroic change. The company is headquartered in Chicago, IL.

Strata Oncology, Inc. manufactures oncology drugs. It provides comprehensive testing, portfolio of treatments, peace of mind. The company was founded by Daniel D. Rhodes, Scott Tomlin and Keith T. Flaherty in 2015 and is headquartered Ann Arbor, MI.

Jumpcode Genomics, Inc. provides healthcare services. The company is headquartered in Carlsbad, CA.

Invivium Capital Management LLC (Invivium Capital) is a venture capital firm founded in 2022. The firm is headquartered in Chicago, Illinois.

Veniti, Inc. operates as a medical device company which focuses on the treatment of venous insufficiency. Its products include VENI RF Plus which uses radio frequency generated steam to destroy problematic veins that manifest as varicose veins; VENI Vena Cava Filter system which is engineered to improve the accuracy, efficiency of deployment, placement and retrieval; and VICI Venous Stent which is designed specifically for the treatment of venous outflow obstruction. The company was founded by Sean C. Morris and Mark Klopp in 2009 and is headquartered in Fremont, CA.